Has DexCom (DXCM) Outpaced Other Medical Stocks This Year?
https://www.zacks.com/stock/news/2246003/has-dexcom-dxcm-outpaced-other-medical-stocks-this-year?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_1-2246003
Mar 26, 2024 - Here is how DexCom (DXCM) and Anika Therapeutics (ANIK) have performed compared to their sector so far this year.
0
DexCom (DXCM) Upgraded to Buy: What Does It Mean for the Stock?
https://www.zacks.com/stock/news/2248016/dexcom-dxcm-upgraded-to-buy-what-does-it-mean-for-the-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2248016
Mar 29, 2024 - DexCom (DXCM) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
0
DexCom (DXCM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
https://www.zacks.com/stock/news/2262800/dexcom-dxcm-q1-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2262800
Apr 25, 2024 - While the top- and bottom-line numbers for DexCom (DXCM) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
0
Pages: 12
<Page 2